This gap in knowledge prompts further investigation into the potential link between ZFAS1, STAT3, and glucose metabolism, with the goal of elucidating novel mechanisms of metabolic reprogramming in CML. This evidence concerns the gene ZFAS1 and chronic myelogenous leukemia, BCR-ABL1 positive.